Clinical experience with lorazepam in the treatment of neurotic patients.
D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy*; D001247:Asthenia / Q000139:chemically induced; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D008569:Memory Disorders / Q000139:chemically induced; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D010698:Phobic Disorders / Q000188:drug therapy; D010919:Placebos; D011618:Psychotic Disorders / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D001570:Benzodiazepinones; D002722:Chlorobenzenes; D006993:Hypnotics and Sedatives; D010919:Placebos; D014149:Tranquilizing Agents; D003975:Diazepam